-
April 21: The Week in Cancer News
Awareness of HPV link to cancer has declined, and more frequent COVID-19 boosters authorized for people who are immunocompromised.
by Eric Fitzsimmons
-
Nudging Our Way to Better Cancer Care
Researchers use insights from behavioral economics to encourage taking recommended actions in health care.
by Kevin McLaughlin
-
Post-surgery Option for Liver Cancer
New study finds drug combination after surgery helps prevent recurrence in liver cancer patients.
by Thomas Celona
-
Chronic Stress and Cancer
Accumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of stress.
by Thomas Celona
-
Forward Look
Progress in Personalized Cancer VaccinesStudy finds mRNA vaccine can help prevent cancer recurrence in advanced melanoma patients.
by Thomas Celona
-
April 14: The Week in Cancer News
Treatment vaccines are on the horizon, and immunotherapy drugs are effective in treating multiple myeloma.
by Kevin McLaughlin
-
Preventable Emergency Department Visits Trending Upwards for Patients with Cancer
Attentive care can manage conditions that cause patients to seek emergency care, but patients with concerning symptoms should still go to the hospital or urgent care center.
by Sandra Gordon
-
April 7: The Week in Cancer News
New therapy approved for locally advanced or metastatic bladder cancer, and court ruling could lead to cost hikes for certain cancer screenings.
by Thomas Celona
-
Most Cancer Doctors, Patients Interested in Integrative Care
A nationwide survey found strong support for complementary therapies like massage and meditation, but also significant barriers to access.
by Kyle Bagenstose
-
March 31: The Week in Cancer News
Immunotherapies poised to change care in advanced endometrial cancer, and the end of pandemic protection expected to result in loss of health coverage for 15 million people.
by Eric Fitzsimmons
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore